{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:38:49Z","timestamp":1790419129173,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM089820"],"award-info":[{"award-number":["GM089820"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.gene.2019.144289","type":"journal-article","created":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T02:06:30Z","timestamp":1576289190000},"page":"144289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["IFNL4: Notable variants and associated phenotypes,"],"prefix":"10.1016","volume":"730","author":[{"given":"Michelle Z.","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah S.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.gene.2019.144289_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166998","article-title":"Donor IFNL4 genotype is associated with early post-transplant fibrosis in recipients with hepatitis C","volume":"11","author":"Aiken","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.gene.2019.144289_b0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-\u0394G allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.gene.2019.144289_b0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jhep.2015.03.033","article-title":"Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A","volume":"63","author":"Akamatsu","year":"2015","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.gene.2019.144289_b0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200221","article-title":"Impact of IFN lambda 3\/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients","volume":"13","author":"Annibali","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gene.2019.144289_b0025","doi-asserted-by":"crossref","unstructured":"Ansari, M. A., Pedergnana, V., Camila, L. C. Ip., Magri, A., Von Delft, A., Bonsall, D., Chaturvedi, N., Bartha, I., Smith, D., Nicholson, G., McVean, G., Trebes, A., Piazza, P., Fellay, J., Cooke, G., Foster, G. R., Consortium, S.-H., Barnes, E., Ball, J., Brainard, D., Burgess, G., Cooke, G., Dillon, J., Foster, G. R., Gore, C., Guha, N., Halford, R., Herath, C., Holmes, C., Howe, A., Hudson, E., Irving, W., Khakoo, S., Klenerman, P., Koletzki, D., Martin, N., Massetto, B., Mbisa, T., McHutchison, J., McKeating, J., McLauchlan, J., Miners, A., Murray, A., Shaw, P., Simmonds, P., Spencer, C. C. A., Targett-Adams, P., Thomson, E., Vickerman, P., Zitzmann, N., Hudson, E., McLauchlan, J., Simmonds, P., Bowden, R., Klenerman, P., Barnes, E., Spencer, C. C. A., 2017. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nat. Genet. 49, 666. doi:10.1038\/ng.3835.","DOI":"10.1038\/ng.3835"},{"key":"10.1016\/j.gene.2019.144289_b0030","doi-asserted-by":"crossref","unstructured":"Bibert, S., Roger, T., Calandra, T., Bochud, M., Cerny, A., Semmo, N., Duong, F. H. T., Gerlach, T., Malinverni, R., Moradpour, D., Negro, F., M\u00fcllhaupt, B., Bochud, P.-Y., Cohort Study S. H. C., 2013. IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction. J. Exp. Med, 210(6), 1109\u20131116. doi:10.1084\/jem.20130012.","DOI":"10.1084\/jem.20130012"},{"issue":"13","key":"10.1016\/j.gene.2019.144289_b0035","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1097\/QAD.0000000000000379","article-title":"The IFNL3\/4 DeltaG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients","volume":"28","author":"Bibert","year":"2014","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.gene.2019.144289_b0040","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1097\/QAD.0000000000002004","article-title":"Interferon lambda 3\/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma","volume":"32","author":"Bibert","year":"2018","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.gene.2019.144289_b0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.24678","article-title":"IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes","volume":"55","author":"Bochud","year":"2012","journal-title":"Hepatology"},{"issue":"D1","key":"10.1016\/j.gene.2019.144289_b0050","doi-asserted-by":"crossref","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","article-title":"The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019","volume":"47","author":"Buniello","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0055","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gene.2019.144289_b0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","article-title":"Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1","volume":"131","author":"Conjeevaram","year":"2006","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.gene.2019.144289_b0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003773","article-title":"Type I and Type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia","volume":"9","author":"Crotta","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.gene.2019.144289_b0070","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1038\/ncomms7422","article-title":"Interferon-lambda rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease","volume":"6","author":"Eslam","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/ng.3836","article-title":"IFN-lambda3, not IFN-lambda4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis","volume":"49","author":"Eslam","year":"2017","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.gene.2019.144289_b0080","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1099\/jgv.0.000522","article-title":"IFN-lambda4 desensitizes the response to IFN-alpha treatment in chronic hepatitis C through long-term induction of USP18","volume":"97","author":"Fan","year":"2016","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0085","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.21853","article-title":"Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response","volume":"46","author":"Feld","year":"2007","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/QAD.0000000000000052","article-title":"IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha\/ribavirin therapy failure in hepatitis C virus\/HIV-1 coinfected patients","volume":"28","author":"Franco","year":"2014","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0095","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","article-title":"Interferon-lambda Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness","volume":"46","author":"Galani","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.gene.2019.144289_b0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcv.2014.01.006","article-title":"Nonsynonymous variant Pro70Ser (rs117648444) in IFNL4 gene identifies carriers of the rs368234815 DeltaG allele with higher HCV RNA decline during the first 4 weeks of pegylated interferon and ribavirin therapy in HCV-1 patients","volume":"59","author":"Galmozzi","year":"2014","journal-title":"J. Clin. Virol."},{"issue":"7262","key":"10.1016\/j.gene.2019.144289_b0105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.gene.2019.144289_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003514","article-title":"A systematic analysis of host factors reveals a Med23-interferon-\u03bb regulatory axis against herpes simplex virus type 1 replication","volume":"9","author":"Griffiths","year":"2013","journal-title":"PLoS Pathog."},{"issue":"23","key":"10.1016\/j.gene.2019.144289_b0115","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/emboj.2013.232","article-title":"Interferon lambda 4 signals via the IFN\u03bb receptor to regulate antiviral activity against HCV and coronaviruses","volume":"32","author":"Hamming","year":"2013","journal-title":"EMBO J."},{"key":"10.1016\/j.gene.2019.144289_b0120","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ni.3180","article-title":"Interferon-\u03bb and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection","volume":"16","author":"Hern\u00e1ndez","year":"2015","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.gene.2019.144289_b0125","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1053\/j.gastro.2010.04.049","article-title":"Hepatic ISG expression is associated with genetic variation in IL28B and the outcome of IFN therapy for chronic hepatitis C","volume":"139","author":"Honda","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gene.2019.144289_b0130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2012.11.012","article-title":"Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir","volume":"58","author":"Karino","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.gene.2019.144289_b0135","doi-asserted-by":"crossref","unstructured":"Kelemen, L. E., Lawrenson, K., Tyrer, J., Li, Q., Lee, J. M., Seo, J. H., Phelan, C. M., Beesley, J., Chen, X., Spindler, T. J., Aben, K. K., Anton-Culver, H., Antonenkova, N., Australian Cancer, S., Australian Ovarian Cancer Study, G., Ovarian Cancer Association, C. (2015). Genome-wide significant risk associations for mucinous ovarian carcinoma. Nat. Genet. 47(8), 888\u2013897. doi:10.1038\/ng.3336.","DOI":"10.1038\/ng.3336"},{"issue":"10","key":"10.1016\/j.gene.2019.144289_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004681","article-title":"Selection on a variant associated with improved viral clearance drives local, adaptive pseudogenization of interferon lambda 4 (IFNL4)","volume":"10","author":"Key","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.gene.2019.144289_b0145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33354","article-title":"IFN-lambda prevents influenza virus spread from the upper airways to the lungs and limits virus transmission","volume":"7","author":"Klinkhammer","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.gene.2019.144289_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138827","article-title":"Interferon lambda 4 genotype is not associated with recurrence of oral or genital herpes","volume":"10","author":"Lang Kuhs","year":"2015","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.gene.2019.144289_b0160","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1084\/jem.20092720","article-title":"Mouse CD8alpha+ DCs and human BDCA3+ DCs are major producers of IFN-lambda in response to poly IC","volume":"207","author":"Lauterbach","year":"2010","journal-title":"J. Exp. Med."},{"issue":"284","key":"10.1016\/j.gene.2019.144289_b0165","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4304","article-title":"Interferon-\u03bb restricts West Nile virus neuroinvasion by tightening the blood-brain barrier","volume":"7","author":"Lazear","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.gene.2019.144289_b0170","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijid.2016.10.023","article-title":"Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis","volume":"53","author":"Li","year":"2016","journal-title":"Int. J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.gene.2019.144289_b0175","doi-asserted-by":"crossref","first-page":"296","DOI":"10.7326\/0003-4819-132-4-200002150-00008","article-title":"Pathogenesis, natural history, treatment, and prevention of hepatitis C","volume":"132","author":"Liang","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0180","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/hep.27934","article-title":"Hepatitis C virus drug resistance-associated substitutions: state of the art summary","volume":"62","author":"Lontok","year":"2015","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.gene.2019.144289_b0185","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"issue":"13","key":"10.1016\/j.gene.2019.144289_b0190","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1084\/jem.20111680","article-title":"Evolutionary genetic dissection of human interferons","volume":"208","author":"Manry","year":"2011","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.gene.2019.144289_b0195","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/infdis\/jiu557","article-title":"Influence of IFNL3\/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation","volume":"211","author":"Manuel","year":"2015","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0200","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ni.2758","article-title":"The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs","volume":"15","author":"McFarland","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.gene.2019.144289_b0205","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s42003-018-0193-5","article-title":"IFNL4-DeltaG is associated with prostate cancer among men at increased risk of sexually transmitted infections","volume":"1","author":"Minas","year":"2018","journal-title":"Commun. Biol."},{"issue":"22","key":"10.1016\/j.gene.2019.144289_b0210","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa032502","article-title":"Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites","volume":"350","author":"Muir","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"6219","key":"10.1016\/j.gene.2019.144289_b0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1258100","article-title":"Interferon-lambda cures persistent murine norovirus infection in the absence of adaptive immunity","volume":"347","author":"Nice","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0220","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/hep.26506","article-title":"Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.gene.2019.144289_b0225","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2017.06.069","article-title":"IFNL4 genotype is associated with virologic relapse after 8-week treatment with Sofosbuvir, Velpatasvir, and Voxilaprevir","volume":"153","author":"O'Brien","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0230","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jhep.2015.06.035","article-title":"Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance","volume":"63","author":"O'Brien","year":"2015","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.gene.2019.144289_b0235","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/jir.2013.0136","article-title":"IFN-lambda4: the paradoxical new member of the interferon lambda family","volume":"34","author":"O'Brien","year":"2014","journal-title":"J. Interferon. Cytokine Res."},{"issue":"11","key":"10.1016\/j.gene.2019.144289_b0240","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.4049\/jimmunol.1700807","article-title":"IFN-lambda4 attenuates antiviral responses by enhancing negative regulation of IFN signaling","volume":"199","author":"Obajemu","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.gene.2019.144289_b0245","doi-asserted-by":"crossref","DOI":"10.1089\/jir.2019.0044","article-title":"The IFN-lambda4 conundrum: when a good interferon goes bad","author":"Onabajo","year":"2019","journal-title":"J. Interferon. Cytokine Res."},{"issue":"18","key":"10.1016\/j.gene.2019.144289_b0250","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.2012.3516","article-title":"New genetic discoveries and treatment for hepatitis C","volume":"307","author":"Pacanowski","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jir.2015.0096","article-title":"Comparative functional analysis of 12 mammalian IFN-lambda4 orthologs","volume":"36","author":"Paquin","year":"2016","journal-title":"J. Interferon. Cytokine Res."},{"issue":"10","key":"10.1016\/j.gene.2019.144289_b0260","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1089\/jir.2019.0013","article-title":"Impact of IFNL4 genetic variants on sustained virologic response and viremia in hepatitis C virus genotype 3 patients","volume":"39","author":"Pedergnana","year":"2019","journal-title":"J. Interferon. Cytokine Res."},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.28255","article-title":"Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3","volume":"63","author":"Peiffer","year":"2016","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.gene.2019.144289_b0270","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/jir.2019.0043","article-title":"Genetics of the human interferon lambda region","volume":"39","author":"Prokunina-Olsson","year":"2019","journal-title":"J. Interferon. Cytokine Res."},{"issue":"2","key":"10.1016\/j.gene.2019.144289_b0275","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.gene.2019.144289_b0280","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B Is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"issue":"19","key":"10.1016\/j.gene.2019.144289_b0285","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.gene.2019.144289_b0290","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0295","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.gene.2019.144289_b0300","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.4049\/jimmunol.1003988","article-title":"Regulation of IFN-lambda1 promoter activity (IFN-lambda1\/IL-29) in human airway epithelial cells","volume":"187","author":"Siegel","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0305","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1038\/s41598-017-04186-7","article-title":"IFN-lambda4 potently blocks IFN-alpha signalling by ISG15 and USP18 in hepatitis C virus infection","volume":"7","author":"Sung","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.gene.2019.144289_b0310","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.gene.2019.144289_b0315","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-[alpha] and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"issue":"21","key":"10.1016\/j.gene.2019.144289_b0320","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1158\/1078-0432.CCR-18-1060","article-title":"IFNL4-DeltaG allele is associated with an interferon signature in tumors and survival of African-American men with prostate cancer","volume":"24","author":"Tang","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2019.144289_b0325","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.1038\/ncomms6699","article-title":"Reduced IFNlambda4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes","volume":"5","author":"Terczynska-Dyla","year":"2014","journal-title":"Nat. Commun."},{"issue":"7265","key":"10.1016\/j.gene.2019.144289_b0330","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.gene.2019.144289_b0335","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.gene.2019.144289_b0340","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/j.gastro.2018.12.014","article-title":"Multi-ancestry genome-wide association study of spontaneous clearance of hepatitis C virus","volume":"156","author":"Vergara","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.gene.2019.144289_b0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/cmi.2014.127","article-title":"Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infection","volume":"13","author":"Wong","year":"2016","journal-title":"Cell. Mol. Immunol."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919309485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919309485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:01:52Z","timestamp":1778544112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111919309485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":69,"alternative-id":["S0378111919309485"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2019.144289","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFNL4: Notable variants and associated phenotypes,","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2019.144289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"144289"}}